Viewing StudyNCT03816163

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 12:39 PM
Last Modification Date: 2024-10-26 @ 1:02 PM
Study NCT ID: NCT03816163
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-09
First Post: 2019-01-23
Brief Title: A Study of Zolbetuximab IMAB362 in Adults With Pancreatic Cancer
Sponsor: Astellas Pharma Global Development Inc
Organization: Astellas Pharma Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer
Metastatic Pancreatic Cancer
Keywords:
Name View
CLDN 182 View
metastatic pancreatic cancer View
IMAB362 View
nab-paclitaxel View
gemcitabine View
zolbetuximab View
metastatic pancreatic adenocarcinoma View
pancreatic cancer View